Avedro, Inc., company update: Epi-on crosslinking (CXL) and PiXL technology

Article
Conferences|ASCRS

ICYMI: Here's what's in the 2019 pipeline

Rajesh Rajpal, MD, Chief Medical Officer of Avedro, Inc., provides a company update on Epi-on crosslinking (CXL) and PiXL technology during the 2019 ASCRS conference in San Diego.

Recent Videos
Related Content
Underlying corneal pathologies with alopecia areata

Underlying corneal pathologies with alopecia areata

Article
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Podcast
OKYO Pharma announces plans for Phase 2 clinical trial of OK-101 in neuropathic corneal pain

OKYO Pharma announces plans for Phase 2 clinical trial of OK-101 in neuropathic corneal pain

Article
(Podcast) Confronting Demodex blepharitis: From rude awakening to FDA-approved solution

(Podcast) Confronting Demodex blepharitis: From rude awakening to FDA-approved solution

Podcast
Surgical taming of neurotrophic keratopathy

Surgical taming of neurotrophic keratopathy

Article
Nonablative treatment offers safety, efficacy, and multiple applications for the cornea

Nonablative treatment offers safety, efficacy, and multiple applications for the cornea

Article
© 2024 MJH Life Sciences

All rights reserved.